Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study

Ultramicronized palmitoylethanolamide (um-PEA), a compound with antioxidant, anti-inflammatory and neuroprotective properties, appears to be a potential adjuvant treatment for early stages of Coronavirus disease 2019 (COVID-19). In our study, we enrolled 90 patients with confirmed diagnosis of COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Albanese, Maria, Marrone, Giulia, Paolino, Agostino, Di Lauro, Manuela, Di Daniele, Francesca, Chiaramonte, Carlo, D’Agostini, Cartesio, Romani, Annalisa, Cavaliere, Alessandro, Guerriero, Cristina, Magrini, Andrea, Mercuri, Nicola Biagio, Di Daniele, Nicola, Noce, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878249/
https://www.ncbi.nlm.nih.gov/pubmed/35215365
http://dx.doi.org/10.3390/ph15020253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878249/
https://www.ncbi.nlm.nih.gov/pubmed/35215365
http://dx.doi.org/10.3390/ph15020253

Ejemplares similares